Form 4: Bausch Health Director Sells Shares for Tax Payments

Bausch Health Companies Inc. Director Frank D. Lee sold 15,912 common shares to cover tax obligations from a previously vested equity award.

Summary

• Frank D. Lee, a Director of Bausch Health Companies Inc. (BHC), reported a sale of common shares.
• The transaction involved the disposition of 15,912 common shares, no par value, on August 21, 2025.
• The shares were sold at a weighted average price of $7.66 per share, with individual transactions ranging from $7.66 to $7.665.
• The purpose of the sale was to provide funds for estimated tax payments arising from a previously vested equity award granted to the Issuer's non-employee directors.
• Following this transaction, Frank D. Lee beneficially owns 73,795 common shares directly.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, tax-related insider transaction and does not indicate any fundamental change in the company's prospects or the director's confidence.

Positives

• The underlying equity award indicates standard compensation practices for non-employee directors, aligning their interests with shareholders.

Negatives

• No direct negative implications for the company's operations or financial health from this routine, tax-related insider sale.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The sale of shares was executed to cover estimated tax payments associated with a previously vested equity award granted to non-employee directors.

Industry Context

This transaction is a routine insider sale, common across industries, where executives or directors sell a portion of their vested equity awards to cover tax liabilities. It does not reflect a change in the company's operational performance or strategic direction, but rather a personal financial management event.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, tax-related sale by a director and not indicative of a change in company fundamentals.
• Employees: No direct impact.

Key Dates

Keywords

Bausch Health Companies Inc., BHC, Insider Trading, Form 4, Director Share Sale, Equity Award, Tax Payments, Rule 10b5-1(c)